Interleukin‐1 antagonism in acute gout: Is targeting a single cytokine the answer?
Open Access
- 1 July 2010
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 62 (10), 2845-2849
- https://doi.org/10.1002/art.27635
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Comparison of Oral Prednisolone/Paracetamol and Oral Indomethacin/Paracetamol Combination Therapy in the Treatment of Acute Goutlike Arthritis: A Double-Blind, Randomized, Controlled TrialAnnals of Emergency Medicine, 2007
- Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β InhibitionThe New England Journal of Medicine, 2006
- Effectiveness of interventions for the treatment of acute and prevention of recurrent gout—a systematic reviewRheumatology, 2006
- EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)Annals Of The Rheumatic Diseases, 2006
- Gout-associated uric acid crystals activate the NALP3 inflammasomeNature, 2006
- Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study.2005
- Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD)Rheumatology, 2005
- Gout epidemiology: results from the UK General Practice Research Database, 1990-1999Annals Of The Rheumatic Diseases, 2005
- Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population.2004
- Epidemiology of gout: is the incidence rising?2002